Published in Oncogene on April 09, 1998
Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Mol Cell Biol (2001) 1.96
Involvement of protective autophagy in TRAIL resistance of apoptosis-defective tumor cells. J Biol Chem (2008) 1.84
Mechanism of action of interleukin-2 (IL-2)-Bax, an apoptosis-inducing chimaeric protein targeted against cells expressing the IL-2 receptor. Biochem J (2003) 1.59
Bodyguards and assassins: Bcl-2 family proteins and apoptosis control in chronic lymphocytic leukaemia. Immunology (2005) 1.41
Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes Dev (1998) 1.24
A systematic characterization of mitochondrial proteome from human T leukemia cells. Mol Cell Proteomics (2004) 1.24
Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma. J Cell Biol (2010) 1.11
Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J Virol (2002) 1.08
Epstein-Barr virus BALF1 is a BCL-2-like antagonist of the herpesvirus antiapoptotic BCL-2 proteins. J Virol (2002) 1.05
Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection. J Virol (2001) 1.05
Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus. J Virol (1999) 1.04
High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma. PLoS One (2009) 1.03
Downregulation of RUNX1 by RUNX3 requires the RUNX3 VWRPY sequence and is essential for Epstein-Barr virus-driven B-cell proliferation. J Virol (2009) 0.98
Harnessing the cell death pathway for targeted cancer treatment. Am J Cancer Res (2010) 0.91
The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity. PLoS One (2013) 0.89
Efficient repair of A/C mismatches in mouse cells deficient in long-patch mismatch repair. EMBO J (2000) 0.84
Analysis of mutational signatures in exomes from B-cell lymphoma cell lines suggest APOBEC3 family members to be involved in the pathogenesis of primary effusion lymphoma. Leukemia (2015) 0.82
Loss of the proteins Bak and Bax prevents apoptosis mediated by histone deacetylase inhibitors. Cell Cycle (2013) 0.81
Caspase inhibition blocks cell death and enhances mitophagy but fails to promote T-cell lymphoma. PLoS One (2011) 0.79
Controlling TRAIL-mediated caspase-3 activation. Leukemia (2004) 0.78
Sall2 is required for proapoptotic Noxa expression and genotoxic stress-induced apoptosis by doxorubicin. Cell Death Dis (2015) 0.78
N-(1-pyrenyl) maleimide induces bak oligomerization and mitochondrial dysfunction in Jurkat Cells. Biomed Res Int (2015) 0.78
Lipid analogues as potential drugs for the regulation of mitochondrial cell death. Br J Pharmacol (2014) 0.77
Impact of Exogenous Galectin-9 on Human T Cells: CONTRIBUTION OF THE T CELL RECEPTOR COMPLEX TO ANTIGEN-INDEPENDENT ACTIVATION BUT NOT TO APOPTOSIS INDUCTION. J Biol Chem (2015) 0.75
Identification of the breast cancer susceptibility gene BRCA2. Nature (1996) 17.14
Molecular characterization of mitochondrial apoptosis-inducing factor. Nature (1999) 14.41
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (1994) 8.73
The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci U S A (1993) 4.66
Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet (1997) 4.16
Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. Oncogene (1995) 2.91
BRCA2 mutations in primary breast and ovarian cancers. Nat Genet (1996) 2.91
Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol (1991) 2.58
Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet (1994) 2.45
The BZLF1 protein of EBV has a coiled coil dimerisation domain without a heptad leucine repeat but with homology to the C/EBP leucine zipper. Oncogene (1991) 2.25
A polymorphic stop codon in BRCA2. Nat Genet (1996) 1.95
A G protein gamma subunit-like domain shared between RGS11 and other RGS proteins specifies binding to Gbeta5 subunits. Proc Natl Acad Sci U S A (1998) 1.94
High level expression of p27(kip1) and cyclin D1 in some human breast cancer cells: inverse correlation between the expression of p27(kip1) and degree of malignancy in human breast and colorectal cancers. Proc Natl Acad Sci U S A (1997) 1.81
The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. J Biol Chem (1994) 1.45
GTPase activating specificity of RGS12 and binding specificity of an alternatively spliced PDZ (PSD-95/Dlg/ZO-1) domain. J Biol Chem (1998) 1.45
The p36 isoform of BAG-1 is translated by internal ribosome entry following heat shock. Oncogene (2001) 1.44
Familial nontoxic multinodular thyroid goiter locus maps to chromosome 14q but does not account for familial nonmedullary thyroid cancer. Am J Hum Genet (1997) 1.42
MicroRNAs: key players in carcinogenesis and novel therapeutic targets. Eur J Surg Oncol (2008) 1.42
A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet (1992) 1.34
Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. Gastroenterology (1999) 1.26
Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1. Oncogene (2001) 1.25
Fidelity of G protein beta-subunit association by the G protein gamma-subunit-like domains of RGS6, RGS7, and RGS11. Proc Natl Acad Sci U S A (1999) 1.24
v-raf suppresses apoptosis and promotes growth of interleukin-3-dependent myeloid cells. Oncogene (1994) 1.23
Familial cylindromatosis (turban tumour syndrome) gene localised to chromosome 16q12-q13: evidence for its role as a tumour suppressor gene. Nat Genet (1995) 1.21
Screening hCHK2 for mutations. Science (2000) 1.20
E2F-1:DP-1 induces p53 and overrides survival factors to trigger apoptosis. Mol Cell Biol (1995) 1.20
Epigenetic therapy: histone acetylation, DNA methylation and anti-cancer drug discovery. Curr Cancer Drug Targets (2009) 1.11
Pharmacological inhibitors of NF-kappaB accelerate apoptosis in chronic lymphocytic leukaemia cells. Oncogene (2006) 1.08
Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus. J Virol (1999) 1.04
Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential? Br J Cancer (2008) 1.03
Absence of evidence for a familial breast cancer susceptibility gene at chromosome 8p12-p22. Oncogene (2000) 1.03
High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers. Br J Cancer (1999) 1.03
A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53. Nucleic Acids Res (2001) 1.02
Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic. Arrest, apoptosis, and microtubule assembly in human breast cancer cells. Cancer Res (2000) 0.97
BCR-ABL tyrosine kinase activity regulates the expression of multiple genes implicated in the pathogenesis of chronic myeloid leukemia. Cancer Res (2000) 0.95
Linkage and LOH studies in 19 cylindromatosis families show no evidence of genetic heterogeneity and refine the CYLD locus on chromosome 16q12-q13. Hum Genet (2000) 0.95
Nuclear BAG-1 expression inhibits apoptosis in colorectal adenoma-derived epithelial cells. Apoptosis (2005) 0.94
The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours. Int J Cancer (2000) 0.93
BAG-1 expression and function in human cancer. Br J Cancer (2002) 0.92
BAG-i expression in human breast cancer: interrelationship between BAG-1 RNA, protein, HSC70 expression and clinico-pathological data. J Pathol (2002) 0.91
Differential splicing of Epstein-Barr virus immediate-early RNA. J Virol (1992) 0.90
Brn-3a activates the expression of Bcl-x(L) and promotes neuronal survival in vivo as well as in vitro. Mol Cell Neurosci (2001) 0.90
Familial craniofacial fibrous dysplasia: absence of linkage to GNAS1 and the gene for cherubism. J Med Genet (2000) 0.90
2-MeOE2bisMATE induces caspase-dependent apoptosis in CAL51 breast cancer cells and overcomes resistance to TRAIL via cooperative activation of caspases. Apoptosis (2004) 0.89
The histone deacetylase inhibitors vorinostat and romidepsin downmodulate IL-10 expression in cutaneous T-cell lymphoma cells. Br J Pharmacol (2011) 0.89
Novel sulfasalazine analogues with enhanced NF-kB inhibitory and apoptosis promoting activity. Apoptosis (2005) 0.89
A20 RNA expression is associated with undifferentiated nasopharyngeal carcinoma and poorly differentiated head and neck squamous cell carcinoma. J Pathol (1999) 0.88
Melatonin, a natural programmed cell death inducer in cancer. Curr Med Chem (2012) 0.88
Differential regulation of cell survival by CD40. Apoptosis (2003) 0.88
BRCA1 and BRCA2 germline mutations in Sardinian breast cancer families and their implications for genetic counseling. Ann Oncol (2002) 0.87
Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer. J Med Genet (1999) 0.87
Infrequent bax gene mutations in B-cell lymphomas. J Pathol (1998) 0.87
Absence of linkage to the ataxia telangiectasia locus in familial breast cancer. Hum Genet (1993) 0.85
Distinct promoters mediate constitutive and inducible Bcl-XL expression in malignant lymphocytes. Oncogene (2006) 0.83
DNA binding of USF is required for specific E-box dependent gene activation in vivo. Oncogene (1999) 0.81
Impact of delayed reperfusion of myocardial hibernation on myocardial ultrastructure and function and their recoveries after reperfusion in a pig model of myocardial hibernation. Cardiovasc Pathol (2000) 0.81
Vav and Ras induce fibroblast transformation by overlapping signaling pathways which require c-Myc function. Oncogene (1995) 0.80
Identification of a novel human BCL-X promoter and exon. Oncogene (2000) 0.79
BAG-1 immunostaining and survival in early breast cancer. J Clin Oncol (2001) 0.79
Multicentric breast cancer: clonality and prognostic studies. Breast Cancer Res Treat (2010) 0.78
Inhibition of superoxide dismutase by 2-methoxyoestradiol analogues and oestrogen derivatives: structure-activity relationships. Anticancer Drug Des (2002) 0.78
The BAG-1 cochaperone is a negative regulator of p73-dependent transcription. Br J Cancer (2009) 0.77
Bcl-2-related proteins and cancer. Biochem Soc Trans (1999) 0.76
The biological response of MCF7 breast cancer cells to proteosome inhibition or gamma-radiation is unrelated to the level of p53 induction. Apoptosis (1999) 0.76
A combined iron and folic-acid preparation in the prophylaxis of anaemia of pregnancy. Practitioner (1966) 0.76
Lupus-related mitral valve disease: embolic coronary occlusion as a unique cause of myocardial infarction. Can J Cardiol (1997) 0.75
Quantitative measurement of estrogen and progesterone receptors in breast lumps using image cytometry. Anal Quant Cytol Histol (1997) 0.75
An interstitial tandem duplication of 9p23-24 coexists with a mutation in the BRCA2 gene in the germ line of three brothers with breast cancer. Cancer Res (1998) 0.75
Reversibility and pathohistological basis of left ventricular remodeling in hibernating myocardium. Cardiovasc Pathol (2001) 0.75
DNA ploidy on cytologic and tissue sections of breast lumps. A comparison using image analysis. Anal Quant Cytol Histol (1996) 0.75
"Diverticula" of anterior mitral valve leaflet as a cause of subvalvular aortic stenosis. J Heart Valve Dis (1996) 0.75